Article
FDA flags issues at Coherus partner's China plant for cancer drug
Rating:
0.0
Views:
49
Likes:
1
Library:
1
Coherus BioSciences Inc said on Wednesday the U.S. Food and Drug Administration (FDA) had flagged three observations at its partner's manufacturing site in China when the agency was conducting inspections related to its experimental cancer drug.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value